On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization

Abstract Background PTV concept is presumed to introduce excessive and inconsistent GTV dose in lung stereotactic body radiotherapy (SBRT). That GTV median dose prescription (D 50 ) and robust optimization are viable PTV–free solution (ICRU 91 report) to harmonize the GTV dose was investigated by co...

Full description

Bibliographic Details
Main Authors: Ronnie Wing King Leung, Mark Ka Heng Chan, Chi-Leung Chiang, Matthew Wong, Oliver Blanck
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Radiation Oncology
Online Access:http://link.springer.com/article/10.1186/s13014-020-01573-9
_version_ 1818315965182509056
author Ronnie Wing King Leung
Mark Ka Heng Chan
Chi-Leung Chiang
Matthew Wong
Oliver Blanck
author_facet Ronnie Wing King Leung
Mark Ka Heng Chan
Chi-Leung Chiang
Matthew Wong
Oliver Blanck
author_sort Ronnie Wing King Leung
collection DOAJ
description Abstract Background PTV concept is presumed to introduce excessive and inconsistent GTV dose in lung stereotactic body radiotherapy (SBRT). That GTV median dose prescription (D 50 ) and robust optimization are viable PTV–free solution (ICRU 91 report) to harmonize the GTV dose was investigated by comparisons with PTV–based SBRT plans. Methods Thirteen SBRT plans were optimized for 54 Gy / 3 fractions and prescribed (i) to 95% of the PTV (D 95 ) expanded 5 mm from the ITV on the averaged intensity project (AIP) CT, i.e., PTVITV, (ii) to D 95 of PTV derived from the van Herk (VH)‘s margin recipe on the mid–ventilation (MidV)–CT, i.e., PTVVH, (iii) to ITV D 98 by worst case scenario (WCS) optimization on AIP,i.e., WCSITV and (iv) to GTV D 98 by WCS using all 4DCT images, i.e., WCSGTV. These plans were subsequently recalculated on all 4DCT images and deformably summed on the MidV–CT. The dose differences between these plans were compared for the GTV and selected normal organs by the Friedman tests while the variability was compared by the Levene’s tests. The phase–to–phase changes of GTV dose through the respiration were assessed as an indirect measure of the possible increase of photon fluence owing to the type–B dose engine. Finally, all plans were renormalized to GTV D 50 and all the dosimetric analyses were repeated to assess the relative influences of the SBRT planning concept and prescription method on the variability of target dose. Results By coverage prescriptions (i) to (iv), significantly smaller chest wall volume receiving ≥30 Gy (CWV30) and normal lung ≥20 Gy (NLV20Gy) were achieved by WCSITV and WCSGTV compared to PTVITV and PTVVH (p > 0.05). These plans differed significantly in the recalculated and summed GTV D 2 , D 50 and D 98 (p <  0.05). The inter–patient variability of all GTV dose parameters is however equal between these plans (Levene’s tests; p > 0.05). Renormalizing these plans to GTV D 50 reduces their differences in GTV D 2 , and D 98 to insignificant level (p > 0.05) and their inter–patient variability of all GTV dose parameters. None of these plans showed significant differences in GTV D 2 , D 50 and D 98 between respiratory phases, nor their inter–phase variability is significant. Conclusion Inconsistent GTV dose is not unique to PTV concept but occurs to other PTV–free concept in lung SBRT. GTV D 50 renormalization effectively harmonizes the target dose among patients and SBRT concepts of geometric uncertainty management.
first_indexed 2024-12-13T09:13:55Z
format Article
id doaj.art-a5a93963323440128fa3508144dcee98
institution Directory Open Access Journal
issn 1748-717X
language English
last_indexed 2024-12-13T09:13:55Z
publishDate 2020-05-01
publisher BMC
record_format Article
series Radiation Oncology
spelling doaj.art-a5a93963323440128fa3508144dcee982022-12-21T23:52:53ZengBMCRadiation Oncology1748-717X2020-05-0115111610.1186/s13014-020-01573-9On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimizationRonnie Wing King Leung0Mark Ka Heng Chan1Chi-Leung Chiang2Matthew Wong3Oliver Blanck4Department of Clinical Oncology, TuenMun HospitalDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg-EssenDepartment of Clinical Oncology, The University of Hong KongDepartment of Clinical Oncology, TuenMun HospitalDepartment of Radiotherapy, University Hospital EssenAbstract Background PTV concept is presumed to introduce excessive and inconsistent GTV dose in lung stereotactic body radiotherapy (SBRT). That GTV median dose prescription (D 50 ) and robust optimization are viable PTV–free solution (ICRU 91 report) to harmonize the GTV dose was investigated by comparisons with PTV–based SBRT plans. Methods Thirteen SBRT plans were optimized for 54 Gy / 3 fractions and prescribed (i) to 95% of the PTV (D 95 ) expanded 5 mm from the ITV on the averaged intensity project (AIP) CT, i.e., PTVITV, (ii) to D 95 of PTV derived from the van Herk (VH)‘s margin recipe on the mid–ventilation (MidV)–CT, i.e., PTVVH, (iii) to ITV D 98 by worst case scenario (WCS) optimization on AIP,i.e., WCSITV and (iv) to GTV D 98 by WCS using all 4DCT images, i.e., WCSGTV. These plans were subsequently recalculated on all 4DCT images and deformably summed on the MidV–CT. The dose differences between these plans were compared for the GTV and selected normal organs by the Friedman tests while the variability was compared by the Levene’s tests. The phase–to–phase changes of GTV dose through the respiration were assessed as an indirect measure of the possible increase of photon fluence owing to the type–B dose engine. Finally, all plans were renormalized to GTV D 50 and all the dosimetric analyses were repeated to assess the relative influences of the SBRT planning concept and prescription method on the variability of target dose. Results By coverage prescriptions (i) to (iv), significantly smaller chest wall volume receiving ≥30 Gy (CWV30) and normal lung ≥20 Gy (NLV20Gy) were achieved by WCSITV and WCSGTV compared to PTVITV and PTVVH (p > 0.05). These plans differed significantly in the recalculated and summed GTV D 2 , D 50 and D 98 (p <  0.05). The inter–patient variability of all GTV dose parameters is however equal between these plans (Levene’s tests; p > 0.05). Renormalizing these plans to GTV D 50 reduces their differences in GTV D 2 , and D 98 to insignificant level (p > 0.05) and their inter–patient variability of all GTV dose parameters. None of these plans showed significant differences in GTV D 2 , D 50 and D 98 between respiratory phases, nor their inter–phase variability is significant. Conclusion Inconsistent GTV dose is not unique to PTV concept but occurs to other PTV–free concept in lung SBRT. GTV D 50 renormalization effectively harmonizes the target dose among patients and SBRT concepts of geometric uncertainty management.http://link.springer.com/article/10.1186/s13014-020-01573-9
spellingShingle Ronnie Wing King Leung
Mark Ka Heng Chan
Chi-Leung Chiang
Matthew Wong
Oliver Blanck
On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
Radiation Oncology
title On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
title_full On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
title_fullStr On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
title_full_unstemmed On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
title_short On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
title_sort on the pitfalls of ptv in lung sbrt using type b dose engine an analysis of ptv and worst case scenario concepts for treatment plan optimization
url http://link.springer.com/article/10.1186/s13014-020-01573-9
work_keys_str_mv AT ronniewingkingleung onthepitfallsofptvinlungsbrtusingtypebdoseengineananalysisofptvandworstcasescenarioconceptsfortreatmentplanoptimization
AT markkahengchan onthepitfallsofptvinlungsbrtusingtypebdoseengineananalysisofptvandworstcasescenarioconceptsfortreatmentplanoptimization
AT chileungchiang onthepitfallsofptvinlungsbrtusingtypebdoseengineananalysisofptvandworstcasescenarioconceptsfortreatmentplanoptimization
AT matthewwong onthepitfallsofptvinlungsbrtusingtypebdoseengineananalysisofptvandworstcasescenarioconceptsfortreatmentplanoptimization
AT oliverblanck onthepitfallsofptvinlungsbrtusingtypebdoseengineananalysisofptvandworstcasescenarioconceptsfortreatmentplanoptimization